Antidepressant activity of anti-hyperglycemic agents in experimental models: A review.

Diabetes & Metabolic Syndrome
Nariman EssmatAmr A A Mahmoud

Abstract

Diabetes Mellitus (DM) and depression occur comorbidly and share some pathophysiological mechanisms. The course of depression in patients with the two conditions is severe. Treatment of depression in diabetic patients requires special attention because most of psychopharmacological agents can worsen glycemic control. This article aims to review studies evaluating the antidepressant effect of anti-hyperglycemic agents from preclinical perspective. A literature search was performed with PubMed and Google Scholar using relevant keywords (antidiabetic; diabetes; depression; antidepressant; animals) to extract relevant studies evaluating the antidepressant activity of anti-hyperglycemic agents in experimental models. Several studies have reported that some traditional anti-hyperglycemic agents reduce depression-like behavior in the absence or presence of diabetes. These drugs include insulin, glyburide, metformin, pioglitazone, vildagliptin, liraglutide, and exenatide. The antidepressant activity of anti-hyperglycemic agents may be mediated by reducing the blood glucose level, ameliorating the central oxidative stress and inflammation, and regulating the hypothalamic-pituitary-adrenal axis (HPAA). Drugs which have both antidiabetic ...Continue Reading

References

Aug 4, 2001·Psychosomatic Medicine·M de GrootP J Lustman
Sep 10, 2004·The New England Journal of Medicine·Hannele Yki-Järvinen
Oct 24, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·S AliK Khunti
Dec 13, 2007·Nature Reviews. Neuroscience·Robert DantzerKeith W Kelley
Feb 9, 2011·Psychosomatics·Sarah M MarkowitzSteven A Safren
Jun 17, 2011·Postȩpy higieny i medycyny doświadczalnej·Marzena GrzybowskaMaria Olszewska
Mar 13, 2012·Pharmacological Reviews·Anita E Autry, Lisa M Monteggia
Nov 29, 2012·Current Opinion in Psychiatry·Michael Deuschle
Mar 28, 2013·Metabolic Brain Disease·Carlos Alberto Yasin WayhsCarmen Regla Vargas
Apr 18, 2013·The Journal of Endocrinology·Hiranya PintanaSiriporn C Chattipakorn
Apr 20, 2014·Current Diabetes Reports·Richard I G HoltSherita Hill Golden
Jul 31, 2014·Medical Science Monitor Basic Research·Ipek Komsuoglu CelikyurtIlhan Tarkun
Nov 29, 2014·Cell Biochemistry and Function·Carlos Alberto Yasin WayhsCarmen Regla Vargas
May 9, 2015·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Naveen SharmaHong-Won Suh
Jun 4, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·K RådholmC J Östgren
Jan 3, 2016·Psychoneuroendocrinology·Rozita H AnderbergKarolina P Skibicka
Jan 7, 2016·Frontiers in Molecular Neuroscience·Ruey-Horng ShihChuen-Mao Yang
Feb 10, 2016·Basic & Clinical Pharmacology & Toxicology·Caio C SestileElisabeth A Audi
Feb 9, 2017·Canadian Journal of Physiology and Pharmacology·Sattar OstadhadiAhmad-Reza Dehpour
Feb 14, 2017·Journal of Diabetes and Its Complications·Chen-Pin WangSara E Espinoza
Nov 1, 2017·Journal of Neuroinflammation·Wen-Jun SuChun-Lei Jiang
Mar 3, 2018·Diabetes Research and Clinical Practice·N H ChoB Malanda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here